Rahimi Zohreh, Chamaie-Nejad Foroogh, Saeidi Shohreh, Rahimi Ziba, Ebrahimi Ali, Shakiba Ebrahim, Vaisi-Raygani Asad
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic Address:
Int J Fertil Steril. 2018 Jul;12(2):147-151. doi: 10.22074/ijfs.2018.5270. Epub 2018 Mar 18.
The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR) γ Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influence on lipid and lipoprotein profiles of patients.
The present cross-sectional study consisted of 50 women with PCOS, who referred to the Kermanshah University of Medical Sciences Clinic between April and October 2015, and 233 unrelated age-matched healthy women from the same region (West Iran). The PPARγ Pro12Ala and PPARγ C161T polymorphisms were genotyped using the polymerase chain reaction-restriction fragment length polymorphism method. Fasting blood sugar (FBS), serum triglycerides (TG), cholesterol, low density lipoprotein- cholesterol (LDL-C), high density lipoproteincholesterol (HDL-C) and estradiol levels were measured.
The serum level of estradiol was significantly lower in PCOS patients compared to healthy women. The PPARγ Pro12Ala (CG) genotype increased the risk of PCOS 2.96-fold. The frequency of the PPARγ T allele (at C161T) was 21% in patients and 17.2% in controls with no significant difference (P=0.52). In all studied individuals, the PPARγ CG genotype was associated with significantly higher levels of TG. However, significantly lower levels of total cholesterol and LDL-C were observed in PPARγ TT individuals compared with those with the CC genotype. Within the PCOS group, the PPARγ CG genotype was significantly associated with lower levels of estradiol compared with the CC genotype. Also, the CG genotype was significantly associated with higher levels of TG when compared with the CC genotype.
Our study shows that, unlike PPARγ C161T, PPARγ Pro12Ala is associated with the risk of PCOS. Also, we found that the lipid and lipoprotein profiles significantly vary based on PPARγ Pro12Ala and C161T genotypes.
本研究的目的是阐明过氧化物酶体增殖物激活受体(PPAR)γ Pro12Ala和C161T基因多态性在多囊卵巢综合征(PCOS)发病机制中的作用及其对患者脂质和脂蛋白谱的影响。
本横断面研究包括2015年4月至10月间转诊至克尔曼沙赫医科大学诊所的50例PCOS女性患者,以及来自同一地区(伊朗西部)的233名年龄匹配的无亲缘关系健康女性。采用聚合酶链反应-限制性片段长度多态性方法对PPARγ Pro12Ala和PPARγ C161T基因多态性进行基因分型。测定空腹血糖(FBS)、血清甘油三酯(TG)、胆固醇、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和雌二醇水平。
与健康女性相比,PCOS患者的血清雌二醇水平显著降低。PPARγ Pro12Ala(CG)基因型使PCOS风险增加2.96倍。PPARγ T等位基因(C161T处)在患者中的频率为21%,在对照组中为17.2%,差异无统计学意义(P=0.52)。在所有研究个体中,PPARγ CG基因型与显著更高的TG水平相关。然而,与CC基因型个体相比,PPARγ TT个体的总胆固醇和LDL-C水平显著降低。在PCOS组内,与CC基因型相比,PPARγ CG基因型与较低的雌二醇水平显著相关。此外,与CC基因型相比,CG基因型与较高的TG水平显著相关。
我们的研究表明,与PPARγ C161T不同,PPARγ Pro12Ala与PCOS风险相关。此外,我们发现脂质和脂蛋白谱根据PPARγ Pro12Ala和C161T基因型有显著差异。